Suppliers / Johnson Matthey Pharmaceutical Materials

Johnson Matthey Pharmaceutical Materials

United States Updated 9 July 2026

Johnson Matthey Pharmaceutical Materials is an API manufacturer based in United States. It holds one active US drug master file across a filed portfolio of 3 molecules.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Carmustine US FDA 1
Fentanyl SFDA (Saudi Arabia) 1
Fentanyl Base SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Carmustine API Fentanyl API

Questions about Johnson Matthey Pharmaceutical Materials

Does Johnson Matthey Pharmaceutical Materials hold a US DMF or a CEP?
Johnson Matthey Pharmaceutical Materials holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Johnson Matthey Pharmaceutical Materials make?
3 molecules are on record against Johnson Matthey Pharmaceutical Materials, including Carmustine, Fentanyl and Fentanyl Base. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Johnson Matthey Pharmaceutical Materials comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 1 molecule Apitoria Pharma shares 1 molecule Natco Pharma shares 1 molecule Specgx shares 1 molecule Veranova Lp shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability